Exelixis Inc. Common Stock vs WEC Energy Group Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $62.28 (market cap $15.12B), while WEC Energy Group Inc. Common Stock trades at $107.87 (market cap $34.78B). The key difference: WEC Energy Group Inc. Common Stock is far larger — about 2.3× Exelixis Inc. Common Stock's market cap, and WEC Energy Group Inc. Common Stock pays a 3.57% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 3 Days and WEC Energy Group Inc. Common Stock for 0 Days on average.
| EXEL | WEC | |
|---|---|---|
Market Cap | $15.12B | $34.78B |
Volume | 2,752,905 | 2,317,952 |
Sector | Health | Utilities |
52-Week High | $60.99 | $118.85 |
52-Week Low | $34.54 | $100.78 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $14.44B | $57.74B |
Dividend Yield | — | 3.57% |
Signals from Pluang's Aura AI — not financial advice
EXEL trades at $59.51, down 0.52% on the day but near its 52-week high of $61.66 reached on October 12, 2026. The stock shows strong technical momentum with bullish moving averages and has consistently beaten earnings estimates in recent quarters. Recent news highlights include a three-month FDA review delay for zanzalintinib but continued growth in CABOMETYX revenue, which surpassed $3 billion annually.
The outlook remains positive with strong profitability metrics (35.33% net margin, 44.39% ROE) and projected revenue growth to $2.4 billion in 2026. Key risks include regulatory delays for new drug approvals and competitive pressures in oncology. Analyst consensus is mixed with 48% buy ratings but a price target of $52.33 suggesting potential downside from current levels.
WEC Energy Group trades at $105.87, up 0.92% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q2 2026 EPS of $0.91 vs. $0.804 expected) and improving profitability (net margin 16.7%). Recent news highlights growing data center demand as a key growth driver, with the company engaging in large-scale customer discussions for 400-500 megawatt projects.
WEC presents a compelling utility investment with stable cash flows and dividend potential, though faces interest rate sensitivity. Analyst consensus targets $118.33 (12% upside) with majority Hold ratings. Key risks include regulatory pressures and capital expenditure requirements for infrastructure expansion through 2030.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →WEC Energy Group is a Midwest electric and natural gas utility holding company whose subsidiaries, including We Energies and Wisconsin Public Service, deliver electricity and natural gas to customers in Wisconsin, Illinois, Michigan, and Minnesota.
Read more on WEC →